Applied Clinical Trials-02-01-2022

Six best practices and three key mistakes to avoid in new technology space.

Phase I/II study in cancer patients showcases eClinical effectiveness.

With large shift to decentralized strategies, industry roles appear set for change.

2022 EU initiative provides hope for improvement of trial regulations.

Looking to US Medicare/Medicaid to increase patient participation.

Michael J. Hennessy, Sr., was the beloved chairman and CEO of MJH Life Sciences, parent company of Applied Clinical Trials.

Click the title above for a link to open the Applied Clinical Trials January/February 2022 issue in an interactive PDF format.

Uncertainty over experimental medicines calls for review of AA process.

Dr. Harish Dave, CEO of Singapore-based AUM Biosciences, discusses evolving strategies for Asian biopharmaceutical enterprises.

The need for specific capabilities to suit DCT business models is creating new challenges in team building, training, and development.

New requirements must be put in place to ensure data quality and integrity.

Optimizing feasibility through increased data collection.